InMed Pharmaceuticals Inc. (INM) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2024 | $9.3K | -94.2% |
| 2023 | $160.0K | +309.2% |
| 2022 | $39.1K | +2167.1% |
| 2021 | $1.7K | -95.9% |
| 2020 | $42.6K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2024 | $9.3K | -94.2% |
| 2023 | $160.0K | +309.2% |
| 2022 | $39.1K | +2167.1% |
| 2021 | $1.7K | -95.9% |
| 2020 | $42.6K | — |